chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose 1 in 2018, did not complete my second; This case was reported by a consumer via  interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was self reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination. The reporter reported his/her physician recommended to restart the series. The reporter wanted to know what were the recommendations for restarting the series.
Within 1 hour of receiving the flu vaccine the persons eyes began to water and developed excessive nasal congestion. Drainage from eyes increased as time went on and then changed to purulent drainage also complained of upper lip numbness. Excessive nasal congestion persisted for hours. Initially, the person took Motrin and symptoms decreased slightly. Later took Dimetapp nasal spray which also decreased symptoms. (OMIC).
Patient reported temp to 102F and rigors the night he received Gardasil in the office. Took anti-pyretics and went to sleep. Symptoms resolved by morning. No other reported associated sx.
11/13/05 - wife stated" - started with face on face & fever. 11/14/05 - seen in ER with rash to face, low grade fever, body aches & chills. Diagnosed with: viral syndrome with rash vs: reaction to MMR vaccine. Sent home on Benadryl & Zyrtec.  11/15/05 - followed up - afebrile at this time. Rash had spread to face, arms, chest & back.
Patient received Moderna COVID-19 vaccine as first dose 7 months ago inadvertently. He received Pfizer brand of vaccine as second dose. No side effects or adverse reactions reported.
This spontaneous report as received from a registered nurse refers to a patient of unknown age, unknown gender. The patient was vaccinated subcutaneously with one dose of MMR II (lot number not reported) that expired on 26-OCT-2012 on 30-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effects reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Pt received the vaccine and withing about 5 minutes started feeling dizzy and light headed, tingling in arm and fingers, and nausea.  Sat with pt and provided a bottle of water and an ice pack.  Checked blood pressure after about 10 minutes and it was 133/87 and pulse was 98.  Remained with pt until family member returned and she felt well enough to leave the store.  Refused emergency services.
This spontaneous report was received from a health care professional refers to patients of unknown age. On an unknown date, no more than 10 patients were vaccinated with doses of improperly stored GARDASIL, (lot number, expiry date and route was not reported) which were exposed to 26 Fahrenheit from 28-NOV-2012 to 15-MAR-2012. Concomitant medications were not reported. No adverse effect was reported. Additional information has been requested.
Hives over trunk area, extending under armpits, on neck, and down legs to the knee area. 11/5/2009, vac records and VAERS report stating patient with c/o's hives and itching.  Parent called Pediatrician and told to monitor, give Benadryl and epi pen if worsens. Tx: benadryl and cortisone cream.
Pt called Health Department this am stating she had a reaction from her Pneumonia vaccine.  Pt stated that she has a "itchy, prickly" rash to both arms and across the top of her shoulders.  Pt denies seeing her physician stating "I know what it is so why should I see my doctor."  Pt states that rash began about 8-12 hours after vaccine administration and that she has used "Anti-Itch Cream."  Pt denies use of Benadryl stating "I am out here at the house and I am not going out to buy any."
Joint pain, Muscle discomfort, slight dizziness, slight nausea Arm pain accompanied by being hot to the touch Fatigue, tiredness (lasted beyond the fever stage) Chills (felt like I was in a deep freeze) Site itchiness, odd sensation, like fiberglass Also, the other arm where I got the first show became activated re: pain, itchiness, sensations as previously described Did not take any Tylenol or any other similar medication either before the injection or afterward, even to this day.Fever (began at 99.4 and rose to 100.6 for the remainder of the day on Friday, followed by sustained spike over the next number of hours and over the next day (Saturday) up to 102, leveled off and began to reduce over the following hours and day (Sunday) first to 101.2, 100.4 and then to 99.4, 99.2 until it broke on Monday)
Patient tested positive for Covid-19 on 06/30/2022 at the Hospital.  Patient was then accepted to hospice on 07/02/2022.  Patient arrived to hospital via ambulance from hospital accompanied by EMT's.  Patient presented nonverbal, decreased, negative purposeful movement, lungs with rales throughout, abdomen soft with hypoactive bowel sounds, skin hot to the touch and pale, left and right hands with 3+ edema, 4LNC of O2.  Patient presented actively dying.  Terminal diagnosis at facility was Covid-19.
Pt recv vax in 9/97; subsequently pt exp cervical lymphadenopathy
Pt's mother denied asthma prior to receiving Flu Meds on 10/208. Mom reported he had cough on Saturday but worsened yesterday; severe cough v SOB. She gave multiple albuterol neb treatments, which helped Per pt's chart, he has asthma attacks wever winter season.
Pain in left arm, left shoulder and left shoulder blade. The pain comes and goes, but has not waned since getting the vaccine shot in April.
had the shingles vaccine and still got shingles/suspected vaccination failure; huge bout of shingles/could´t have worse; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR004113   Additional Information: GSK receipt date: 26-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the vaccine and still got a huge bout of shingles. The patient knew that same with a few other people and no, his/her could not had worse without the shot. The case was linked with case US2022AMR156040, reported by same reporter for different patients. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR156040:same reporter
Dizziness   Narrative: To whom it may concern patient is requesting  administrative leave for 03/07/2021 and 03/08/2021 because of dizziness  and feeling unbalanced due to taking the second COVID-19 shot
The day after she noted a burning pain in thighs her down both legs and her back and also involves both her forearms.  Any movement, especially walking causes more pain in there legs and back.  It is difficult for her to separate whether this is in the muscles or joints.  The pain has been getting worse and over the last few days she has noted swelling of her LLE and says that she can't put her shoe on.  Despite the swelling on the L, she says the R leg hurts more.
hypertension; This spontaneous case was reported by a pharmacist and describes the occurrence of HYPERTENSION (hypertension) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient did not have any other medical states.  Previously administered products included for Drug use for unknown indication: METOPROLOL and ATORVASTATIN. Past adverse reactions to the above products included No adverse event with ATORVASTATIN and METOPROLOL.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (hypertension). At the time of the report, HYPERTENSION (hypertension) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
My lips start swelling last night, I thought it was a pimple but in the morning I woke up with total swelling of my lips.
Headache, head pressure, aches, muscle cramps, night sweats , redness and swelling at and surrounding injection site.
The patient received the monovalent 6-11 Moderna 0.5ml dose instead of the updated Moderna booster 6-11 dose. Patient had headache and a sore arm from vaccination per mother.
Headache daily for 2 weeks now, lightheaded, dizzy, nauseous, some nauseas
Mild allergic reaction including rash on neck, chest and global itching after 15 minutes    Was given benadryl which led to symptom improvement in about another 30 minutes.
pt recv vax & 2wk post vax pt exp unexplained elevation of liver enzymes;f/u from a RN indicated cannot recall any problems w/hep B vax;
No adverse effects reported.; one dose of MMR II (lot number R018526, expiration date 10/04/2020) was inadvertently given by the intramuscular route, instead of subcutaneous on 7/08/2019; Information has been received from a pharmacist referring to a 22 years old patient of unknown gender. Information about concurrent condition, concomitant medication, drug reactions/allergies and medical history was not provided.  The reporter reported that one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # R018526, expiration date was 04-OCT-2020, intramuscular; strength and dose were not reported) for prophylaxis was inadvertently given by the intramuscular route, instead of subcutaneous (Incorrect route of product administration) on 08-JUL-2019. No adverse effects was reported. No PQC.
Initial media report received via medical information specialist on 13 Dec 2010: The patient had history of asthma. On an unknown date, FLUVIRIN was administered to a patient under 4 years of age. The patient fell ill after receiving the FLUVIRIN dose. The patient also developed bad coughing fits within 24 hours of getting flu vaccine. The parent assumed that it had brought on his asthma and took him to the hospital. The patient was given an unspecified inhaler. The treating physician commented that the symptoms were nothing to do with the jab. At the time of the report, no further information or causality assessment was reported.
Information has been received from a registered nurse referring to a 9 week old patient of unknown gender. On 11-AUG-2015 the patient was vaccinated with ROTATEQ (oral, lot # K022990, expiration date and dose were unknown) which excursed the storage temperature. No reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
bad reaction; concern the vaccines were given too soon; This spontaneous report was received from a female patient of unknown age reporting on herself. No information was provided regarding the patient's relevant medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies.  On an unknown date, the patient was vaccinated with the third dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, frequency, route of administration, lot number, expiration date, vaccination scheme and anatomical location were not reported), as prophylaxis.        On an unknown date, the patient experienced a bad reaction. She further stated, she was worried that they gave it too soon (inappropriate schedule of product administration).  At the time of the report, she recovered from the adverse reaction, as she mentioned she was fine.  Causality assessment was not provided by the reporter.
itchy swollen eyelids which then developed  into welts on eyelids and were still very red and itchy through the whole day after administration of vaccine.  by third day they were reddened but no raised areas.
I'm sorry this appears to be a misunderstanding.  The adverse reaction was not vaccine related.  I thought since it was a 6 month follow up you were looking for any vaccine or CoVid development.  Although I was completely vaccinated I came down with CoVid symptoms on 7/28/21 and was tested and confirmed positive on 7/30/31.
Wheezing after 45 minutes administration, continued shortness of breath and dizziness after 10/15/03.
no adverse event; Expired vaccine that was administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered to patient) and NO ADVERSE EVENT (no adverse event) in a 62-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine that was administered to patient).    Concomitant medications were not reported.  Patient age was reported as 62 years and 5 months. ID number was reported as 80777027399. Reportedly, the number of patients at facility that received this Moderna vaccine between 08Apr2022 and 15Dec2022. Treatment medications were not reported
Severe body aches; Fever; Chills; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176), via an unspecified route of administration in the left arm on 29Apr2021 at 10:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication from an unknown date (was taken on occasion, none within 24 hours) and vitamin d nos (VITAMIN D) taken for an unspecified indication from an unknown date. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and sulfa drugs (MANUFACTURER UNKNOWN) for unknown indications on unspecified dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration in the left arm on 08Apr2021 at 09:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 30Apr2021 at 01:30, the patient experienced severe body aches, fever, chills, headache and nausea which lasted approximately 18 hours. The clinical outcome of the events severe body aches, fever, chills, headache and nausea was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Pt developed a 10 x 8 cm local reaction with tenderness of the left thigh.
Pt began to feel sweaty with sensation of throat tightness about 15 min after vaccine was injected.  At that time, all vital signs normal.  Pt did not have tongue swelling and did have a patent airway.   No rash.  Patient was given a total of Benadryl 50mg and Pepcid 20mg.  He was observed for 1.5 hours, during which his vitals remained normal, airway remained patent, and no rash was noted.  Patient continued to have sensation of throat tightness after the observation period, and we recommended that he proceed to the ER.  He declined to do so.  He was then given a syringe of epinephrine 0.3mL of 1:1000 solution for the ride home.  He was driven home by his parents.  We attempted to contact him later that evening but received no response.
Blister on wrist, arm; Red arm; Swelling arm; Painful arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of blister in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 01-MAR-2023, the patient received the 2nd dose of Shingrix. On 02-MAR-2023, 1 days after receiving Shingrix, the patient experienced blister (Verbatim: Blister on wrist, arm), erythema of extremities (Verbatim: Red arm), swelling arm (Verbatim: Swelling arm) and pain in arm (Verbatim: Painful arm).  The outcome of the blister, erythema of extremities, swelling arm and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the blister, erythema of extremities, swelling arm and pain in arm to be related to Shingrix.     It was unknown if the company considered the blister, erythema of extremities, swelling arm and pain in arm to be related to Shingrix.   Additional Information: GSK Receipt date: 03-Mar-2023 The reporter stated she received the second dose of the vaccine and the next day she developed a blister on her wrist and arm.  The reporter stated her arm was red, swollen, and the area was painful.  AE filed.  The reporter stated she sought medical guidance form the registered pharmacist at the pharmacy where she received the vaccination. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023034613:same reporter
large lump at the ejection site; arm swelled up; Very painful and couldn't use his arm for several days; This is a spontaneous report from a non-contactable consumer or other non hcp. A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient has medical history, but the conditions were reported as unknown. It was unknown whether the patient had allergies to medications, food or other products. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient's concomitant medications were not reported. It was unknown whether the patient received any other vaccines in four weeks prior vaccination and any other medications within 2 weeks of vaccination. The patient experienced large lump at the ejection site, arm swelled up, and very painful and couldn't use his arm for several days on an unspecified date. It was unknown whether the patient received any treatment for the events. The outcome of all the events was reported as unknown.  No follow-up attempts are possible, information about batch/lot number cannot be obtained. No further information is expected.
Swollen and hot to the touch ant the injection sight extending approximately two inches in diameter.  Severe pain in the arm and high fever of 103.8. Body aches and malaise.
Covid 19 breakthrough.  Received 2 doses.  Ist dose given on 4/16/2021.  No Booster.  Pt presented with generalized weakness, cough, fever and dizziness.
I was covid-19 positive; I was tired; nasal congestion; fever; body aches and feeling very lethargic
The next day it started with neck pain.  Like I slept wrong.  Lasted 2 days or so.  Then I was diagnosed with Bell?s palsy on 1/30/2021
Large local rxn. Peaked 4 days after vaccine. Erythema over entire upper left arm. No other findings. ER concerned about cellulitis - probably not.
On 02/14/2021 developed fever, body aches. On 02/15/2021 I became delirious. Lost feeling in my legs  and fell getting out of bed banging my head on the floor and banging my knees and hands. One day after release from  Hospital on 02/21/2021 I had to return to Hospital because I could not retain urination and a catheter was inserted and I was told to follow up with my Urologist
Information has been received from a pharmacist concerning an adult male patient with a history of multiple myeloma and stem cell transplant who on an unspecified date was vaccinated with a dose of MMR II. Secondary suspect vaccination administered on the same day included a dose of PNEUMOVAX. Other concomitant vaccination administered on the same day included a dose of HIB vaccine (manufacturer unknown). Within 24 hours of vaccination the patient developed encephalitis. Subsequently, the patient recovered from developed encephalitis within 24 hours of vaccination. The patient was also febrile. The patient contacted the pharmacist. At the time of the report, the patient recovered on an unknown date. Upon internal review, encephalitis was considered to be an other important medical event. Additional information has been requested.
This spontaneous report was received from an administrator reporting on multiple patients of unknown age or gender. No information regarding the patients' pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (doses, route of administration, lot numbers or expiration dates were not reported), for prophylaxis. The temperature excursion ranged from 0 to 1 degree Celsius and lasted for 57 hours 25 minutes. It occurred once on an unspecified date and was detected by a Digital Data Logger. There was no previous excursion reported. No adverse effects were reported. This was one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA004567: US-009507513-1706USA004568.
Client was given the flu shot first and then their Pfizer shot. About 10 seconds after the Pfizer shot he started to feel "weird" and breathing faster. His eyes got bigger (dilated) and he put his head back. We're pretty sure he passed out at that point. The pharmacist that administered the shot called for assistance. By the time the assistance came within 15 seconds he was coming around more alert. The emergency kit was grabbed. At that point the administering Pharmacist started to go through a breathing method to calm the client. He started to calm and breath in a normal pattern. The client was alert at this point and responding to questions correctly. The client and father waited close by for observation for 30 minutes. The client was alert, breathing well and feeling much better when they left.